COSSU, CHIARA
COSSU, CHIARA
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern
2024-01-01 Cossu C.; Franceschi V.; Di Lorenzo A.; Bolli E.; Minesso S.; Cotti C.; Conti L.; Donofrio G.
Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models
2023-01-01 Ruiu R.; Cossu C.; Iacoviello A.; Conti L.; Bolli E.; Ponzone L.; Magri J.; Rumandla A.; Calautti E.; Cavallo F.
Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment
2026-01-01 Di Lorenzo A.; Romiti C.; Amaolo A.; Cossu C.; Iacoviello A.; Curcio C.; Forni M.; Zanini C.; Cavallo F.; Ferrauto G.; Di Gregorio E.; Conti L.
Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer
2025-01-01 Tarone L.; Iacoviello A.; Di Lorenzo A.; Verta R.; Cossu C.; Conti L.; Cavallo F.; Riccardo F.
Inducing Antigen‐Specific and Functional Immune Responses in Mice Toward Bovine Herpesvirus 1 and Bovine Respiratory Syncytial Virus by Chimeric Peptides Delivered by Bovine Herpesvirus 4‐Based Vector
2026-01-01 Di Lorenzo, Antonino; Minesso, Sergio; Cossu, Chiara; Franceschi, Valentina; Bolli, Elisabetta; Madia, Vittorio; Conti, Laura; Donofrio, Gaetano
The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes?
2024-01-01 Cossu C.; Di Lorenzo A.; Fiorilla I.; Todesco A.M.; Audrito V.; Conti L.
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody
2026-01-01 Salameh, Ahmad; Bolli, Elisabetta; Iezzi, Manuela; Gagliardi, Christine; Conti, Laura; Cossu, Chiara; Blezinger, Paul; Lamolinara, Alessia; Lewis, Andrew; Curran, Michael A; Cavallo, Federica; Pericle, Federica
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern | 2024 | Cossu C.; Franceschi V.; Di Lorenzo A.; Bolli E.; Minesso S.; Cotti C.; Conti L.; Donofrio G. | |
| Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models | 2023 | Ruiu R.; Cossu C.; Iacoviello A.; Conti L.; Bolli E.; Ponzone L.; Magri J.; Rumandla A.; Calautti E.; Cavallo F. | |
| Dual-Action Theranostic Nanoparticles Delivering Toll-Like Receptor 2 Inhibitors and Chemotherapy Target Breast Cancer Cells and the Tumor Microenvironment | 2026 | Di Lorenzo A.; Romiti C.; Amaolo A.; Cossu C.; Iacoviello A.; Curcio C.; Forni M.; Zanini C.; Cavallo F.; Ferrauto G.; Di Gregorio E.; Conti L. | |
| Exploring Emerging Therapeutic Targets in Osteosarcoma by Revisiting the Immune and Cancer-Intrinsic Hallmarks of Cancer | 2025 | Tarone L.; Iacoviello A.; Di Lorenzo A.; Verta R.; Cossu C.; Conti L.; Cavallo F.; Riccardo F. | |
| Inducing Antigen‐Specific and Functional Immune Responses in Mice Toward Bovine Herpesvirus 1 and Bovine Respiratory Syncytial Virus by Chimeric Peptides Delivered by Bovine Herpesvirus 4‐Based Vector | 2026 | Di Lorenzo, Antonino; Minesso, Sergio; Cossu, Chiara; Franceschi, Valentina; Bolli, Elisabetta; Madia, Vittorio; Conti, Laura; Donofrio, Gaetano | |
| The Role of the Toll-like Receptor 2 and the cGAS-STING Pathways in Breast Cancer: Friends or Foes? | 2024 | Cossu C.; Di Lorenzo A.; Fiorilla I.; Todesco A.M.; Audrito V.; Conti L. | |
| Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody | 2026 | Salameh, Ahmad; Bolli, Elisabetta; Iezzi, Manuela; Gagliardi, Christine; Conti, Laura; Cossu, Chiara; Blezinger, Paul; Lamolinara, Alessia; Lewis, Andrew; Curran, Michael A; Cavallo, Federica; Pericle, Federica |